Transplant lifesaver linked to cancer risk: study investigates

NCT ID NCT02121730

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 2,500 kidney transplant patients to find out why some develop cancer. The main focus was on the immunosuppressive drugs that prevent organ rejection, which can also raise cancer risk. Researchers tracked patients from four regions in France over 10 years to identify key risk factors for skin and solid tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF KIDNEY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure kidney cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER OF KIDNEY

Contacts and locations

Locations

CHU Amiens

Amiens, 80000, France
CHU CAEN

Caen, 14000, France
Chru Lille

Lille, 59000, France
Chu Rouen

Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.